• Homepage Newsroom Pioneering the Future of Healthcare: Cavidi’s BOLD Role in Harnessing the Power of Rare Biomarkers

Pioneering the Future of Healthcare: Cavidi’s BOLD Role in Harnessing the Power of Rare Biomarkers

As the CEO of Cavidi, I stand at the forefront of a monumental shift in medical science that promises to redefine how we approach health and disease. The transformative potential of our new BOLD technology platform to detect low abundance biomarkers is not just a subject of our research; it is the heart of our mission. These biomarkers are harbingers of a new era—an era where the early detection of diseases and personalized interventions are not just possible but are the cornerstones of standard care.

At Cavidi, we are not bystanders in this revolution; we are its catalysts. Our dedication to advancing the research and innovation of rare biomarkers sets us apart as a leading force in this field. We understand that these biomarkers hold the key to unlocking new frontiers in medical diagnostics and treatments, offering unprecedented precision and efficacy. We do this with Exazym® reagent kits, a simple add-on to any ELISA assay to enable ultra-sensitive detection with minimal background. No special hardware or software is required, so anyone can use it.

Our commitment to this cause is unwavering. We have seen the promise of rare biomarkers, and we strive to turn this promise into a tangible reality. The implications of our work are substantial—through our efforts, we are not only shaping the future of medical diagnostics but also ensuring that personalized healthcare is within reach for everyone.

The journey ahead is as exciting as it is challenging, and at Cavidi, we are ready to lead the charge. By embracing the potential of rare biomarkers, we are charting a new course for healthcare breakthroughs that once seemed like distant dreams. I invite you to join us on this journey to explore the potential that lies within these remarkable biological indicators.

Together, let’s unlock the potential of rare biomarkers and transform the landscape of healthcare. Visit Cavidi, and be part of the movement that is setting a new standard in medical science.

John Reisky de Dubnic

CEO, Cavidi



Photo by Drew Beamer on Unsplash